scholarly article | Q13442814 |
P356 | DOI | 10.1161/01.CIR.102.5.572 |
P698 | PubMed publication ID | 10920071 |
P2093 | author name string | Nakamura T | |
Takahashi H | |||
Ueda Y | |||
Katsuda S | |||
Koh E | |||
Juan Y | |||
P2860 | cites work | Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death | Q24312211 |
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cardiomyopathy | Q847583 |
apoptotic process | Q14599311 | ||
P304 | page(s) | 572-578 | |
P577 | publication date | 2000-08-01 | |
P1433 | published in | Circulation | Q578091 |
P1476 | title | Fas-mediated apoptosis in adriamycin-induced cardiomyopathy in rats: In vivo study | |
P478 | volume | 102 |
Q37230844 | A standardized extract of Ginkgo biloba suppresses doxorubicin-induced oxidative stress and p53-mediated mitochondrial apoptosis in rat testes |
Q41817128 | Activation of nuclear factor-kappaB during doxorubicin-induced apoptosis in endothelial cells and myocytes is pro-apoptotic: the role of hydrogen peroxide |
Q41376836 | Acute adriamycin-induced cardiotoxicity is exacerbated by angiotension II |
Q80497061 | Adriamycin induces myocardium apoptosis through activation of nuclear factor kappaB in rat |
Q33186335 | Amlodipine inhibits doxorubicin-induced apoptosis in neonatal rat cardiac myocytes |
Q46374464 | Angiopoietin-1 inhibits doxorubicin-induced human umbilical vein endothelial cell death by modulating fas expression and via the PI3K/Akt pathway |
Q36846891 | Anthracycline-induced chronic cardiotoxicity and heart failure |
Q42045584 | Anti-Fas gene therapy prevents doxorubicin-induced acute cardiotoxicity through mechanisms independent of apoptosis |
Q45876859 | Antiangiogenic systemic gene therapy combined with doxorubicin administration induced caspase 8 and 9-mediated apoptosis in endothelial cells and an anti-metastasis effect. |
Q44417049 | Antioxidants attenuate myocyte apoptosis and improve cardiac function in CHF: association with changes in MAPK pathways |
Q47109012 | Apoptosis and remodeling in adriamycin-induced cardiomyopathy rat model |
Q35642302 | Apoptosis in Anthracycline Cardiomyopathy |
Q63915349 | Apoptosis in the cardiovascular system: incidence, regulation, and therapeutic options |
Q43865653 | Apoptosis in young rats with adriamycin-induced cardiomyopathy--comparison with pirarubicin, a new anthracycline derivative |
Q35770967 | Apoptosis-detecting radioligands: current state of the art and future perspectives |
Q41672498 | Attenuation of doxorubicin-induced cardiotoxicity by esculetin through modulation of Bmi-1 expression |
Q40459939 | CD95/Apo-1/Fas: independent cell death induced by doxorubicin in normal cultured cardiomyocytes. |
Q28388746 | Cardiac-targeted expression of soluble fas attenuates doxorubicin-induced cardiotoxicity in mice |
Q33604134 | Cardiomyocyte death in doxorubicin-induced cardiotoxicity |
Q35657122 | Cardiomyocyte death: mechanisms and translational implications |
Q43151456 | Cardioprotective effect of metformin against doxorubicin cardiotoxicity in rats |
Q36609796 | Caspase-dependent and -independent suppression of apoptosis by monoHER in Doxorubicin treated cells. |
Q36768874 | Cell suicide and caspases |
Q39664570 | Cytoprotective effects of acidosis via heat shock protein HSP27 against the anticancer drug doxorubicin |
Q39486513 | Davallialactone protects against adriamycin-induced cardiotoxicity in vitro and in vivo |
Q37330749 | Dexrazoxane-afforded protection against chronic anthracycline cardiotoxicity in vivo: effective rescue of cardiomyocytes from apoptotic cell death |
Q51742732 | Diazoxide Improves Mitochondrial Connexin 43 Expression in a Mouse Model of Doxorubicin-Induced Cardiotoxicity. |
Q52570040 | Disruption of COX-2 modulates gene expression and the cardiac injury response to doxorubicin. |
Q28579647 | Doxorubicin activates nuclear factor of activated T-lymphocytes and Fas ligand transcription: role of mitochondrial reactive oxygen species and calcium |
Q30411254 | Doxorubicin impairs the insulin-like growth factor-1 system and causes insulin-like growth factor-1 resistance in cardiomyocytes |
Q43847020 | Doxorubicin induces apoptosis and CD95 gene expression in human primary endothelial cells through a p53-dependent mechanism. |
Q44822086 | Doxorubicin induces apoptosis in normal and tumor cells via distinctly different mechanisms. intermediacy of H(2)O(2)- and p53-dependent pathways |
Q37704467 | Doxorubicin induces cardiotoxicity through upregulation of death receptors mediated apoptosis in cardiomyocytes |
Q39888881 | Doxorubicin-induced mitochondrial dysfunction is secondary to nuclear p53 activation in H9c2 cardiomyoblasts |
Q28345320 | Dynamic process of apoptosis in adult rat cardiomyocytes analyzed using 48-hour videomicroscopy and electron microscopy: beating and rate are associated with the apoptotic process |
Q46987056 | Dystrophin-deficiency increases the susceptibility to doxorubicin-induced cardiotoxicity |
Q46800575 | Effects of doxorubicin-containing chemotherapy and a combination with L-carnitine on oxidative metabolism in patients with non-Hodgkin lymphoma |
Q41771261 | Enhanced myocardial fluorodeoxyglucose uptake following Adriamycin-based therapy: Evidence of early chemotherapeutic cardiotoxicity? |
Q28343555 | Ethanol-induced apoptosis in mouse liver: Fas- and cytochrome c-mediated caspase-3 activation pathway |
Q42918384 | Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT. |
Q40598968 | Glutathione S-transferase overexpression protects against anthracycline-induced H9C2 cell death |
Q36674093 | HSP25 down-regulation enhanced p53 acetylation by dissociation of SIRT1 from p53 in doxorubicin-induced H9c2 cell apoptosis |
Q35753015 | Hsp70 may protect cardiomyocytes from stress-induced injury by inhibiting Fas-mediated apoptosis |
Q35078142 | Identification of novel biomarkers for doxorubicin-induced toxicity in human cardiomyocytes derived from pluripotent stem cells. |
Q53626755 | Iloprost attenuates doxorubicin-induced cardiac injury in a murine model without compromising tumour suppression. |
Q34760735 | Increased beta2-adrenoceptors in doxorubicin-induced cardiomyopathy in rat. |
Q44164912 | Indium 111 antimyosin and Tc-99m glucaric acid for noninvasive identification of oncotic and apoptotic myocardial necrosis |
Q21284499 | Induction of Ankrd1 in Dilated Cardiomyopathy Correlates with the Heart Failure Progression |
Q39950138 | Induction of several cytochrome P450 genes by doxorubicin in H9c2 cells. |
Q64094617 | Leveraging the Cardio-Protective and Anticancer Properties of Resveratrol in Cardio-Oncology |
Q34295053 | Liguzinediol improved the heart function and inhibited myocardial cell apoptosis in rats with heart failure |
Q34056422 | Long noncoding RNA MRUL promotes ABCB1 expression in multidrug-resistant gastric cancer cell sublines |
Q37392811 | Matricellular protein CCN1 mediates doxorubicin-induced cardiomyopathy in mice. |
Q36135119 | Mechanism of QSYQ on anti-apoptosis mediated by different subtypes of cyclooxygenase in AMI induced heart failure rats |
Q38038803 | Mechanism of the protective action of taurine in toxin and drug induced organ pathophysiology and diabetic complications: a review |
Q35697472 | Mechanisms of apoptosis in the heart |
Q38388877 | Melatonin Prevents Mitochondrial Damage Induced by Doxorubicin in Mouse Fibroblasts Through Ampk-Ppar Gamma-Dependent Mechanisms |
Q35902403 | MiR-21 Protected Cardiomyocytes against Doxorubicin-Induced Apoptosis by Targeting BTG2. |
Q35274471 | MicroRNA-532-3p regulates mitochondrial fission through targeting apoptosis repressor with caspase recruitment domain in doxorubicin cardiotoxicity |
Q35668883 | Mitochondria play a critical role in cardioprotection |
Q40521043 | Mitochondrial mechanism of heat stress-induced injury in rat cardiomyocyte |
Q38166071 | Molecular basis of cancer-therapy-induced cardiotoxicity: introducing microRNA biomarkers for early assessment of subclinical myocardial injury |
Q34443183 | Molecular mechanisms of apoptosis in the cardiac myocyte |
Q36496257 | Monitoring chemotherapy-induced cardiotoxicity: role of cardiac nuclear imaging |
Q43050245 | N,N-Dimethyl phytosphingosine sensitizes HL-60/MX2, a multidrug-resistant variant of HL-60 cells, to doxorubicin-induced cytotoxicity through ROS-mediated release of cytochrome c and AIF. |
Q35260701 | Noninvasive molecular imaging of apoptosis in a mouse model of anthracycline-induced cardiotoxicity |
Q37090521 | Over-expression of a modified bifunctional apoptosis regulator protects against cardiac injury and doxorubicin-induced cardiotoxicity in transgenic mice |
Q36568908 | Oxidative stress, redox signaling, and metal chelation in anthracycline cardiotoxicity and pharmacological cardioprotection. |
Q53755850 | Pentoxifylline abrogates cardiotoxicity induced by the administration of a single high dose or multiple low doses of doxorubicin in rats. |
Q40591772 | Pifithrin-alpha protects against doxorubicin-induced apoptosis and acute cardiotoxicity in mice |
Q47862697 | Plasma membrane alteration is an early signaling event in doxorubicin-induced apoptosis in the yeast Candida utilis |
Q46960036 | Preventive cardioprotection of erythropoietin against doxorubicin-induced cardiomyopathy |
Q35063194 | Regulation of cardiac myocyte cell death |
Q61809301 | Rosmarinic acid alleviates cardiomyocyte apoptosis via cardiac fibroblast in doxorubicin-induced cardiotoxicity |
Q41813615 | Targeted ultrasound imaging of apoptosis with annexin a5 microbubbles in acute Doxorubicin-induced cardiotoxicity. |
Q35095412 | Targeting ischemic cardiac dysfunction through gene transfer |
Q42937750 | Tempero-spatial dissociation between the expression of Fas and apoptosis after coronary occlusion |
Q34494900 | Thymol and Carvacrol Prevent Doxorubicin-Induced Cardiotoxicity by Abrogation of Oxidative Stress, Inflammation, and Apoptosis in Rats |
Q46769518 | Transcriptional analysis of doxorubicin-induced cardiotoxicity |
Q47572376 | Trastuzumab therapy and the heart: palliation at what cost? |
Q79769921 | Vasculitis induced by immunization with Bacillus Calmette-Guérin followed by atypical mycobacterium antigen: a new mouse model for Kawasaki disease |
Q83034995 | miR-499 regulates mitochondrial dynamics by targeting calcineurin and dynamin-related protein-1 |
Search more.